NCT00156884
- Conditions
- Bone Metastases, Genital Diseases, Genital Diseases, Male, +9 more
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- BC Cancer Agency Vancouver, British Columbia, Canada
Clinical trial condition
Bone Metastases
Explore clinical trials studying Bone Metastases. Study availability and eligibility vary by location and protocol.
114 public trials
18 recruiting studies
Bone Metastases trial results
NCT00264420
- Conditions
- Bone Metastases, Breast Cancer, Breast Diseases, +20 more
- Locations
-
Not specified
NCT00524849
- Conditions
- Bone Metastases, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
NCT00858741
- Conditions
- Bone Metastases, Neurologic Manifestations, Pain, +2 more
- Locations
-
- Radiation Oncology Department at Marilia Medicine school Marília, São Paulo, Brazil
Active, Not Recruiting
9-ING-41 in Patients With Advanced Cancers
NCT03678883
- Conditions
- Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- University of California Irvine Health Orange, California, United States
Active, Not Recruiting
Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)
NCT03795207
- Conditions
- Bone Metastases, Node; Prostate, Prostate Cancer Patients
- Locations
-
- Institut Bergonie Bordeaux, France
- CHRU de Brest Brest, France
- Centre Georges François Leclerc Dijon, France
- Centre Oscar Lambret Lille, France
Active, Not Recruiting
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
NCT04307914
- Conditions
- Bone Cancer, Bone Diseases, Bone Lesion, +16 more
- Locations
-
- TUCH Turku Turku, Finland
- University Hospital Cologne Cologne, Germany
- IOR Bologna, Italy
- CSSP Roma, Italy
Active, Not Recruiting
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
NCT02226276
- Conditions
- Bone Metastases, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
NCT01470105
- Conditions
- Bone Metastases
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- Montefiore Medical Center The Bronx, New York, United States
Active, Not Recruiting
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
NCT02051218
- Conditions
- Bone Metastases, Breast Diseases, Breast Neoplasms, +14 more
- Locations
-
- Landeskrankenhaus Feldkirch Feldkirch, Austria
- Klinikum Wels-Grieskrichen GmbH Wels, Austria
- Uniklinik Düsseldorf, Urologische Klinik Düsseldorf, Germany
- Universitätsklinikum Düsseldorf, Frauenheilkunde/Geburtshilfe Düsseldorf, Germany